SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias board investigation into CEO Jensen Huangs admitted affair, alongside unverified allegations linking his partner to Chinese intelligence, is driving attention as shares fall. Traders are split between viewing the controversy as a temporary overreaction and worrying about leadership, disclosure, and national-security risks, including speculation about Huangs future as CEO.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims is drawing attention ahead of its Q3 report, with traders debating whether the sharp selloff signals weak results or reflects unexplained price pressure; claims of an earnings leak remain speculation. The Lilly obesity-drug agreement adds to the debate over growth potential versus pressure on margins.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp rebound is drawing attention after an Oppenheimer upgrade and Google Clouds use of AMD EPYC processors in its new AI infrastructure; traders also see Nvidia CEO-related headlines prompting a possible rotation into AMD. Bulls point to AI data-center momentum, while skeptics question the valuation and whether the rally can hold.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps surge in a low-volume move that traders describe as a possible short squeeze, despite reports of weak or absent fund inflows. Bulls are chasing the momentum, while skeptics question the moves durability and point to possible hopes for easing inflation or Iran tensions as speculative explanations.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep drop amid a broader crypto sell-off and reports of heavy liquidations has traders focused on whether the decline will continue or find support. The conversation is sharply divided between bearish calls for further losses and holders buying the dip, while some attribute weakness to broader market and regulatory uncertainty.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A sharp, high-volume rebound ahead of Trade Desks Q3 results is driving attention, with traders speculating about short covering and some unverified earnings-leak rumors. The move is contested: bulls hope for a turnaround, while bears point to weakening ad-growth expectations and worry the report or forward guidance could reverse the rally.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics BRIUMVI growth drove a third-quarter revenue beat and higher full-year guidance, but the share-price pullback despite the results has fueled a sell the news debate. Traders are also focused on Phase 3 data for a subcutaneous BRIUMVI formulation as a future catalyst.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Agility Robotics is drawing attention after a sharp selloff following its de-SPAC debut, with traders blaming post-merger selling and raising concerns about dilution and the companys limited revenue and heavy losses. Others see long-term potential in humanoid robotics and point to commercial orders and strategic backers, leaving the discussion split between SPAC skepticism and confidence in the growth story.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention ahead of its earnings report and the scheduled GTA VI launch, with traders focused on preorder demand, managements outlook, and the games potential for recurring online revenue. Bulls see a major growth catalyst, while skeptics argue expectations may already be priced in and warn of a sell-the-news reaction or weaker-than-hoped guidance.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axons quarterly miss and reduced full-year outlook, linked in the discussion to delayed federal Dedrone deployments, have driven a sharp selloff. Traders are split between viewing the drop as a buying opportunity and warning that high valuation and broken price support could mean further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

This account has been verified as an official CLDI representative.

Verified Account

CalidiOfficial

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.

Calidi Biotherapeutics Inc

Neutral Sentiment

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$0.7082
Prev Close	$0.7001
Open	$0.7005
Dividend Yield	0.00%
50-Day Moving Average	$1.01
Beta	1.88
Avg. Volume	46,990.81
PE Ratio	-0.01

52-Week High	$24.96
52-Week Low	$0.62
Market Capitalization	$2.57M
EPS (Annual)	-$95.13
Price to Book	0.47
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

CLDI Fundamentals